| Literature DB >> 33082991 |
Carolyn T Bramante1, Rachel L J Thornton2,3,4,5, Scott J Pilla6,7, Nisa M Maruthur5,6,7, Maya Venkataramani6,7, Jeanne M Clark5,6,7.
Abstract
OBJECTIVE: Understand whether parents lose less weight than nonparents in behavioural weight interventions.Entities:
Keywords: barriers to weight loss; intergenerational obesity; paediatric obesity; parental obesity
Year: 2020 PMID: 33082991 PMCID: PMC7556428 DOI: 10.1002/osp4.436
Source DB: PubMed Journal: Obes Sci Pract ISSN: 2055-2238
FIGURE 1Bar chart that represents the quartiles of percentage of possible intervention visits attended between parents and nonparents. Nonparents are represented by the black bars, and parents are represented by the white bars with black outline. The vertical access represents the percentage of participants who attended each quartile of possible visits (a higher percentage of parents attended the first quartile, and a high percentage of nonparents attended the fourth quartile)
Baseline characteristics
| Characteristics | Participants with children living in the home | Participants with no children living in the home |
|
|---|---|---|---|
|
| 699 | 3,848 | |
| Female gender | 405 (57.9) | 2,246 (58.4) | 0.833 |
| Age, years (mean ± SD) | 54.1 ± 6.4 | 59.9 ± 6.5 |
|
| Married | 528 (75.5) | 2,562 (66.6) |
|
| Unemployed | 116 (16.6) | 838 (21.8) |
|
| BMI (kg m−2, mean ± SD) | 36.2 ± 6.1 | 35.9 ± 5.8 | 0.115 |
| Race/ethnicity | |||
| White, non‐Hispanic | 391 (55.9) | 2,644 (68.7) |
|
| African American | 141 (20.2) | 592 (15.4) | |
| Hispanic/Latino | 135 (19.3) | 482 (12.5) | |
| Other | 32 (4.6) | 130 (3.4) | |
| Number of children in home | |||
| 1 | 457 (65.4) | n/a | n/a |
| 2 | 177 (25.3) | n/a | |
| 3+ | 65 (9.3) | n/a | |
| Highest level of education | |||
| Doctorate or Professional | 47 (6.7) | 194 (5.0) |
|
| BA or Masters | 241 (34.5) | 1,446 (37.6) | |
| High school diploma | 337 (48.3) | 1917 (49.8) | |
| Less than high school | 59 (8.5) | 218 (5.7) | |
| Other | 14 (2.0) | 73 (1.9) | |
| Yearly family income | |||
| >$80,000 | 268 (38.3) | 978 (25.4) |
|
| $60,000–$80,000 | 101 (14.5) | 571 (14.8) | |
| $40,000–$60,000 | 107 (15.3) | 743 (19.3) | |
| $20,000–$40,000 | 112 (16.0) | 763 (19.8) | |
| <$20,000 | 66 (9.4) | 409 (10.6) | |
| Missing | 45 (6.4) | 384 (10.0) | |
| Health Status | |||
| Hypertension | 550 (78.7) | 3,251 (84.5) | 0.76 |
| Dyslipidemia | 457 (65.4) | 2,754 (71.6) | 0.23 |
| Cardiovascular disease | 74 (10.6) | 571 (14.8) | 0.31 |
| Depression | 158 (22.6) | 796 (20.7) | 0.53 |
| Proportion in intervention arm | 383 (54.8) | 1899 (49.4) |
|
Note: Values are mean ± SD or frequency (% of column). Boldface indicates statistical significance (p < 0.05).
Abbreviation: BMI, body mass index.
By χ 2 test (categorical) or t test (continuous).
Includes ‘living in a marriage‐like relationship’.
Includes adjustment for age. Boldface indicates statistical significance (p < 0.05).
Unadjusted and adjusted effects of the intervention on 12‐month changes in clinical parameters and self‐reported behavioural outcomes
| Outcome | Unadjusted effect of intervention (ILI‐DSE) | Adjusted effect of intervention (ILI‐DSE) | ||||
|---|---|---|---|---|---|---|
| Nonparents | Parents |
| Nonparents | Parents |
| |
|
|
|
|
| |||
| Cardiovascular disease risk factors (absolute change unless otherwise indicated) | ||||||
| Weight, % change of baseline weight | −8.2 | −7.2 | 0.04 | −8.3 | −7.1 |
|
| Waist circumference, in cm | −7.0 | −6.1 | 0.14 | −7.1 | −5.7 |
|
| HbA1c, percent | −0.52 | −0.50 | 0.82 | −0.53 | −0.55 | 0.78 |
| Systolic BP, in mmHg | −3.9 | −3.6 | 0.82 | −4.5 | −3.9 | 0.59 |
| Diastolic BP, in mmHg | −1.1 | −1.8 | 0.32 | −1.4 | −2.0 | 0.38 |
| LDL cholesterol, in mg dl−1 | 0.68 | −0.06 | 0.77 | 0.46 | −0.90 | 0.53 |
| HDL cholesterol, in mg dl−1 | 2.2 | 2.0 | 0.78 | 2.12 | 2.20 | 0.91 |
| Triglycerides, in mg dl−1 | −17.1 | −14.2 | 0.71 | −17.7 | −6.1 | 0.06 |
| Stopped using diabetes medications | 7.41 | 6.61 | 0.91 | 7.4 | 6.7 | 0.99 |
| Stopped blood pressure medications | 0.56 | −1.15 | 0.46 | 0.5 | −1.1 | 0.53 |
| Stopped lipid‐lowering medication | 1.83 | −1.09 | 0.52 | 1.8 | −0.7 | 0.52 |
| Resolution of metabolic syndrome | 8.96 | 2.85 | 0.07 | 9.0 | 2.9 | 0.12 |
| Self‐reported behaviours, change between baseline to 12‐month surveys | ||||||
| Times exercised per week | 1.48 | 1.07 | 0.24 | 1.47 | 1.07 | 0.17 |
| Total calories consumed per day | −10.5 | 10.6 | 0.79 | −42.0 | 21.6 | 0.31 |
| Servings of sweets/fats per day | −0.53 | −0.41 | 0.47 | −0.59 | −0.37 | 0.06 |
| Servings of vegetables per day | 0.48 | 0.33 | 0.37 | 0.45 | 0.41 | 0.78 |
| Servings of fruits per day | 0.33 | 0.26 | 0.62 | 0.32 | 0.29 | 0.82 |
| Times eating out per week | −0.37 | −0.48 | 0.59 | −0.41 | −0.46 | 0.79 |
Note: Adjusted for age, gender, race, education, income, marital status, employment status, BMI and baseline values. Boldface indicates statistical significance (p < 0.05).
Abbreviations: DSE, diabetes support and education; HDL, high‐density lipoprotein; ILI, intensive lifestyle intervention; LDL, low‐density lipoprotein.
Interaction between having children in the home and treatment arm by ANCOVA using linear regression (continuous outcome) or logistic regression (binary outcome).
The total is lower than for the unadjusted because some participants were missing the adjusting variables.
Among those using the medication at baseline, the percent that stopped using medication (treatment–control).
Among those with metabolic syndrome at baseline, the percent who had resolution of their metabolic syndrome (treatment–control).
Subgroup analysis of adjusted percent baseline weight lost
| Subgroup | Adjusted effect of intervention (ILI‐DSE) | |||
|---|---|---|---|---|
| Nonparents | Parents |
| ||
| Overall ( | −8.3 | −7.1 |
| |
| Gender | ||||
| Male ( | −9.1 | −7.7 | 0.07 | |
| Female ( | −7.7 | −6.8 | 0.13 | |
| Age | ||||
| Age <54 years ( | −8.1 | −6.7 | 0.13 | |
| Age ≥54 years ( | −8.3 | −7.3 | 0.11 | |
| Race | ||||
| Non‐Hispanic White ( | −8.7 | −8.0 | 0.31 | |
| African American ( | −6.9 | −4.7 |
| |
| Hispanic/Latino ( | −8.3 | −6.8 | 0.15 | |
| Other ( | −6.9 | −8.0 | 0.62 | |
| Gender and race | ||||
| Male | Non‐Hispanic White ( | −9.5 | −8.6 | 0.30 |
| African American ( | −6.7 | −7.1 | 0.79 | |
| Hispanic ( | −7.4 | −5.6 | 0.39 | |
| Other ( | −10.1 | −7.0 | 0.41 | |
| Female | Non‐Hispanic White ( | −8.0 | −7.4 | 0.56 |
| African American ( | −7.0 | −4.1 |
| |
| Hispanic/Latino ( | −8.7 | −7.1 | 0.18 | |
| Other ( | −4.8 | −9.0 | 0.14 | |
| Age and gender | ||||
| Male | <54 years ( | −8.6 | −6.6 | 0.22 |
| ≥54 years ( | −9.1 | −8.6 | 0.60 | |
| Female | <54 years ( | −7.9 | −6.9 | 0.39 |
| ≥54 years ( | −7.7 | −6.2 | 0.08 | |
| Race and age | ||||
| Non‐Hispanic White | <54 years ( | −8.1 | −7.9 | 0.91 |
| ≥54 years ( | −8.8 | −7.9 | 0.35 | |
| African American | < 54 years ( | −7.6 | −3.0 |
|
| ≥ 54 years ( | −6.6 | −5.7 | 0.37 | |
| Hispanic/Latino | < 54 years ( | −6.8 | −5.7 | 0.56 |
| ≥ 54 years ( | −8.3 | −7.7 | 0.67 | |
| Other | <54 years ( | −15.4 | −9.8 | 0.15 |
| ≥54 years ( | −5.4 | −7.3 | 0.57 | |
Note: Boldface indicates statistical significance (p < 0.05).
Abbreviations: BMI, body mass index; DSE, diabetes support and education; ILI, intensive lifestyle intervention.
Adjusted for age, gender, race, (except for the stratifying variable), education, income, marital status, employment status, BMI and baseline weight.
Interaction between having children in the home and treatment arm by ANCOVA using linear regression (continuous outcome) or logistic regression (binary outcome).
FIGURE 2Forest plot of the difference in difference of amount of baseline weight loss between parents and nonparents. Each diamond represents the mean difference in weight loss, nonparents minus parents, for that subgroup. The right side of the central line represents subgroups in which nonparents lost more weight than parents. The left side of the central line represents subgroups in which parents lost more weight than nonparents. The error bars represent 95% confidence intervals for the mean difference in difference values. The x‐axis indicates percent of baseline weight loss
Sensitivity analysis including adjustment for number of children in the home for adjusted effects of the intervention
| Outcome | Unadjusted effect of intervention (ILI‐DSE) | Adjusted effect of intervention (ILI‐DSE) | ||||
|---|---|---|---|---|---|---|
| Nonparents | Parents |
| Nonparents | Parents |
| |
|
|
|
|
| |||
| Cardiovascular disease risk factors (absolute change unless otherwise stated) | ||||||
| Weight, % change of baseline weight | −8.2 | −7.2 | 0.04 | −8.3 | −7.2 | 0.02 |
| Waist circumference, in cm | −7.0 | −6.1 | 0.14 | −7.1 | −5.7 | 0.02 |
| HbA1c, in percent | −0.52 | −0.50 | 0.82 | −0.53 | −0.54 | 0.85 |
| Systolic BP, in mmHg | −3.9 | −3.6 | 0.82 | −4.5 | −3.8 | 0.57 |
| Diastolic BP, in mmHg | −1.1 | −1.8 | 0.32 | −1.4 | −1.9 | 0.39 |
| LDL cholesterol, in mg dl−1 | 0.68 | −0.06 | 0.77 | 0.46 | −0.90 | 0.53 |
| HDL cholesterol, in mg dl−1 | 2.2 | 2.0 | 0.78 | 2.13 | 2.18 | 0.92 |
| Triglycerides, in mg dl−1 | −17.1 | −14.2 | 0.71 | −17.7 | −5.8 | 0.06 |
| Stopped diabetes medications | 7.41 | 6.61 | 0.91 | 7.40 | 6.69 | 0.97 |
| Stopped blood pressure medications | 0.56 | −1.15 | 0.46 | 0.056 | −0.11 | 0.55 |
| Stopped lipid‐lowering medication | 1.83 | −1.09 | 0.52 | 1.85 | −0.68 | 0.57 |
| Resolution of metabolic syndrome | 8.96 | 2.85 | 0.07 | 8.97 | 2.97 | 0.12 |
| Self‐reported behavioural change | ||||||
| Times exercised per week | 1.48 | 1.07 | 0.24 | 1.47 | 1.07 | 0.17 |
| Total calories consumed per day | −10.5 | 10.6 | 0.79 | −42.0 | 21.4 | 0.31 |
| Servings of sweets/fats per day | −0.53 | −0.41 | 0.47 | −0.59 | −0.36 | 0.06 |
| Servings of vegetables per day | 0.48 | 0.33 | 0.37 | 0.45 | 0.41 | 0.80 |
| Servings of fruits per day | 0.33 | 0.26 | 0.62 | 0.32 | 0.30 | 0.83 |
| Times eating out per week | −0.37 | −0.48 | 0.59 | −0.41 | −0.46 | 0.78 |
Note: Adjusted for age, gender, race, education, income, marital status, number of children, employment status, BMI and baseline values.
Abbreviations: DSE, diabetes support and education; HDL, high‐density lipoprotein; ILI, intensive lifestyle intervention; LDL, low‐density lipoprotein.
Interaction between having children in the home and treatment arm by ANCOVA using linear regression (continuous outcome) or logistic regression (binary outcome).
The total is lower than for the unadjusted because some participants were missing the adjusting variables.
Among those using the medication at baseline, the percent who stopped using medication (treatment–control).
Among those with metabolic syndrome at baseline, the percent who had resolution of their metabolic syndrome (treatment–control).
Sensitivity analysis including adjustment for number of children in the home on 1‐year weight outcomes
| Subgroup | Adjusted effect of intervention on % baseline weight lost (ILI‐DSE) | |||
|---|---|---|---|---|
| Nonparents | Parents |
| ||
| Overall ( | −8.3 | −7.2 | 0.02 | |
| Gender | ||||
| Male ( | −9.0 | −7.7 | 0.07 | |
| Female ( | −7.7 | −6.8 | 0.14 | |
| Age | ||||
| Age <54 years ( | −8.1 | −6.8 | 0.15 | |
| Age ≥54 years ( | −8.3 | −7.3 | 0.11 | |
| Race | ||||
| Non‐Hispanic White ( | −8.7 | −8.0 | 0.33 | |
| African American ( | −6.9 | −4.6 | 0.01 | |
| Hispanic/Latino ( | −8.3 | −7.3 | 0.35 | |
| Other ( | −6.9 | −7.8 | 0.69 | |
| Gender and race | ||||
| Male | Non‐Hispanic White ( | −9.5 | −8.5 | 0.28 |
| African American ( | −6.6 | −7.1 | 0.78 | |
| Hispanic ( | −7.3 | −6.5 | 0.70 | |
| Other ( | −10.3 | −6.6 | 0.32 | |
| Female | Non‐Hispanic White ( | −8.0 | −7.4 | 0.55 |
| African American ( | −7.0 | −4.0 | 0.01 | |
| Hispanic/Latino ( | −8.7 | −7.4 | 0.30 | |
| Other ( | −4.9 | −8.9 | 0.15 | |
| Age and gender | ||||
| Male | <54 years ( | −8.6 | −6.6 | 0.20 |
| 54 years ( | −9.1 | −8.6 | 0.60 | |
| Female | <54 years ( | −7.9 | −7.1 | 0.48 |
| ≥54 years ( | −7.7 | −6.1 | 0.08 | |
| Race and age | ||||
| Non‐Hispanic White | <54 years ( | −8.1 | −7.9 | 0.91 |
| ≥54 years ( | −8.8 | −8.0 | 0.41 | |
| African American | <54 years ( | −7.5 | −2.7 | 0.02 |
| ≥54 years ( | −6.6 | −5.6 | 0.32 | |
| Hispanic/Latino | <54 years ( | −6.9 | −6.0 | 0.63 |
| ≥54 years ( | −8.3 | −8.2 | 0.97 | |
| Other | <54 years ( | −15.4 | −9.8 | 0.15 |
| ≥54 years ( | −5.4 | −6.8 | 0.69 | |
Abbreviations: BMI, body mass index; DSE, diabetes support and education; ILI, intensive lifestyle intervention.
Adjusted for age, gender, race, (except for the stratifying variable), education, income, marital status, number of children, employment status, BMI and baseline weight.
Interaction between having children in the home and treatment arm by ANCOVA using linear regression (continuous outcome) or logistic regression (binary outcome).
Changes in weight and cardiovascular risk factors after 1 year of intervention
| Characteristic | Participants with children in the home | Participants with no children in the home |
| ||||
|---|---|---|---|---|---|---|---|
| ILI | DSE |
| ILI | DSE |
| ||
|
| 383 | 316 | 1,899 | 1,949 | |||
| Weight (kg) | |||||||
| Baseline | 102.8 ± 1.0 | 100.8 ± 1.1 | 0.196 | 100.7 ± 0.4 | 101.2 ± 0.4 | 0.412 | |
| Year 1 | 97.0 ± 1.1 | 99.1 ± 1.1 | 0.196 | 91.0 ± 0.4 | 100.5 ± 0.4 | <0.001 | |
| % change | −7.8 ± 0.3 | −0.6 ± 0.3 | <0.001 | −9.0 ± 0.2 | −0.7 ± 0.11 | <0.001 | 0.019 |
| Waist circumference | |||||||
| Baseline (cm) | 115.1 ± 0.8 | 113.2 ± 0.8 | 0.082 | 113.6 ± 0.3 | 114.1 ± 0.3 | 0.231 | |
| Year 1 (cm) | 109.4 ± 0.8 | 111.7 ± 0.9 | 0.055 | 105.3 ± 0.3 | 113.2 ± 0.3 | <0.001 | |
| Change (cm) | −7.3 ± 0.5 | −1.2 ± 0.3 | <0.001 | −7.8 ± 0.2 | −0.8 ± 0.2 | <0.001 | 0.008 |
| Diabetes medication use | |||||||
| Baseline | 337 (88.9) | 277 (88.2) | 0.772 | 1,625 (86.3) | 1,670 (86.7) | 0.711 | |
| Year 1 | 267 (81.9) | 250 (89.3) | 0.010 | 1,431 (77.7) | 1,594 (87.6) | <0.001 | |
| Stopped use | 32 (9.5) | 8 (2.9) | 0.001 | 170 (10.5) | 51 (3.1) | <0.001 | 0.995 |
| HbA1c (%) | |||||||
| Baseline | 7.33 ± 0.06 | 7.43 ± 0.07 | 0.249 | 7.21 ± 0.03 | 7.26 ± 0.03 | 0.140 | |
| Year 1 | 6.82 ± 0.07 | 7.38 ± 0.08 | <0.001 | 6.55 ± 0.02 | 7.10 ± 0.03 | <0.001 | |
| Change | −0.57 ± 0.06 | −0.07 ± 0.06 | <0.001 | −0.66 ± 0.02 | −0.14 ± 0.02 | <0.001 | 0.780 |
| HTN | |||||||
| Baseline | 257 (68.4) | 197 (64.0) | 0.227 | 1,393 (73.9) | 1,410 (73.6) | 0.787 | |
| Year 1 | 223 (69.5) | 185 (66.6) | 0.444 | 1,374 (74.6) | 1,371 (75.7) | 0.437 | |
| Stopped use | 14 (5.5) | 13 (6.6) | 0.607 | 74 (5.3) | 67 (4.8) | 0.497 | 0.525 |
| Systolic BP (mmHg) | |||||||
| Baseline | 127.3 ± 0.9 | 128.0 ± 0.9 | 0.593 | 128.6 ± 0.4 | 129.9 ± 0.4 | 0.014 | |
| Year 1 | 120.7 ± 0.9 | 125.7 ± 1.0 | <0.001 | 121.6 ± 0.4 | 126.9 ± 0.4 | <0.001 | |
| Change | −6.6 ± 0.8 | −3.1 ± 0.9 | 0.004 | −6.8 ± 0.4 | −2.9 ± 0.4 | <0.001 | 0.649 |
| Diastolic BP (mmHg) | |||||||
| Baseline | 71.2 ± 0.5 | 71.7 ± 0.5 | 0.499 | 69.7 ± 0.2 | 70.3 ± 0.2 | 0.060 | |
| Year 1 | 68.7 ± 0.5 | 70.3 ± 0.6 | 0.045 | 66.6 ± 0.2 | 68.4 ± 0.2 | <0.001 | |
| Change | −2.8 ± 0.4 | −1.0 ± 0.5 | 0.007 | −3.1 ± 0.2 | −2.0 ± 0.2 | <0.001 | 0.366 |
| Lipid‐lowering medication use | |||||||
| Baseline | 163 (43.9) | 133 (43.5) | 0.902 | 983 (52.8) | 996 (52.3) | 0.768 | |
| Year 1 | 149 (46.1) | 132 (47.8) | 0.678 | 1,023 (56.1) | 1,094 (61.0) | 0.003 | |
| Stopped use | 35 (21.5) | 30 (22.6) | 0.823 | 170 (17.3) | 154 (15.5) | 0.271 | 0.533 |
| LDL cholesterol (mg dl−1) | |||||||
| Baseline | 115.0 ± 1.6 | 115.8 ± 1.8 | 0.752 | 111.7 ± 0.7 | 112.1 ± 0.7 | 0.692 | |
| Year 1 | 112.8 ± 1.9 | 112.5 ± 1.9 | 0.909 | 106.4 ± 0.7 | 106.1 ± 0.8 | 0.763 | |
| Change | −4.2 ± 1.6 | −4.2 ± 1.6 | 0.979 | −5.2 ± 0.7 | −5.9 ± 0.7 | 0.472 | 0.536 |
| HDL cholesterol (md dl−1) | |||||||
| Baseline | 42.7 ± 0.6 | 43.0 ± 0.7 | 0.689 | 43.6 ± 0.3 | 43.7 ± 0.3 | 0.738 | |
| Year 1 | 45.7 ± 0.7 | 44.1 ± 0.7 | 0.112 | 47.3 ± 0.3 | 45.1 ± 0.3 | <0.001 | |
| Change | 2.7 ± 0.4 | 0.7 ± 0.3 | <0.001 | 3.6 ± 0.2 | 1.4 ± 0.2 | <0.001 | 0.890 |
| Triglycerides (mg dl−1) | |||||||
| Baseline | 191.2 ± 6.5 | 175.1 ± 7.1 | 0.093 | 179.7 ± 2.6 | 180.8 ± 2.6 | 0.773 | |
| Year 1 | 170.0 ± 6.7 | 169.4 ± 6.7 | 0.950 | 147.8 ± 2.0 | 166.4 ± 2.2 | <0.001 | |
| Change | −20.6 ± 6.4 | −6.4 ± 5.0 | 0.093 | −32.3 ± 2.2 | −15.2 ± 2.1 | <0.001 | 0.060 |
| Metabolic syndrome | |||||||
| Baseline | 354 (92.4) | 294 (93.0) | 0.758 | 1,768 (93.1) | 1829 (93.8) | 0.352 | |
| Year 1 | 277 (84.2) | 257 (90.5) | 0.020 | 1,498 (80.1) | 1,695 (92.2) | <0.001 | |
| Resolved | 51 (14.4) | 34 (11.6) | 0.286 | 341 (19.3) | 189 (10.3) | <0.001 | 0.107 |
Abbreviations: DSE, diabetes support and education; HDL, high‐density lipoprotein; ILI, intensive lifestyle intervention; LDL, low‐density lipoprotein.
Interaction between having children in the home and treatment arm by ANCOVA using linear regression (continuous outcome) or logistic regression (binary outcome).
Two‐sample t test.
χ 2 test
Among those using medication or with metabolic syndrome at baseline.
HTN med = Hypertension medication.
Self‐reported behavioural changes in diet and exercise
| Characteristic | Participants with children in the home | Participants with no children in the home |
| ||||
|---|---|---|---|---|---|---|---|
| ILE | DSE |
| ILI | DSE |
| ||
|
| 179 | 148 | 927 | 939 | |||
| Exercise per week | |||||||
| Baseline | 1.41 ± 0.14 | 1.61 ± 0.17 | 0.361 | 1.74 ± 0.07 | 1.73 ± 0.07 | 0.877 | 0.165 |
| Year 1 | 2.86 ± 0.21 | 1.93 ± 0.20 | 0.002 | 3.27 ± 0.09 | 1.79 ± 0.08 | <0.001 | |
| Change | 1.46 ± 0.23 | 0.39 ± 0.21 | <0.001 | 1.51 ± 0.10 | 0.03 ± 0.09 | <0.001 | |
|
| 256 | 215 | 962 | 991 | |||
| Total calories per day | |||||||
| Baseline | 2,103 ± 56 | 2,122 ± 69 | 0.823 | 1951 ± 26 | 1976 ± 28 | 0.507 | 0.293 |
| Year 1 | 1,779 ± 47 | 1,755 ± 63 | 0.764 | 1,620 ± 19 | 1,674 ± 25 | 0.079 | |
| Change | −364 ± 51 | −374 ± 61 | 0.893 | −313 ± 25 | −302 ± 24 | 0.762 | |
| Sweets and fats per day | |||||||
| Baseline | 2.18 ± 0.11 | 2.21 ± 0.14 | 0.856 | 2.09 ± 0.05 | 2.18 ± 0.05 | 0.256 | 0.055 |
| Year 1 | 1.30 ± 0.09 | 1.72 ± 0.12 | 0.004 | 1.08 ± 0.03 | 1.67 ± 0.05 | <0.001 | |
| Change | −0.97 ± 0.12 | −0.56 ± 0.12 | 0.014 | −0.99 ± 0.05 | −0.46 ± 0.05 | <0.001 | |
| Vegetables per day | |||||||
| Baseline | 3.16 ± 0.11 | 3.02 ± 0.11 | 0.360 | 2.88 ± 0.05 | 2.93 ± 0.05 | 0.465 | 0.784 |
| Year 1 | 3.24 ± 0.12 | 2.88 ± 0.12 | 0.039 | 3.18 ± 0.05 | 2.78 ± 0.05 | <0.001 | |
| Change | 0.14 ± 0.11 | −0.19 ± 0.10 | 0.035 | 0.32 ± 0.05 | −0.16 ± 0.05 | <0.001 | |
| Fruits per day | |||||||
| Baseline | 1.88 ± 0.09 | 1.77 ± 0.09 | 0.393 | 1.97 ± 0.05 | 1.98 ± 0.04 | 0.874 | 0.818 |
| Year 1 | 2.12 ± 0.09 | 1.82 ± 0.09 | 0.026 | 2.11 ± 0.04 | 1.80 ± 0.04 | <0.001 | |
| Change | 0.16 ± 0.09 | −0.10 ± 0.09 | 0.038 | 0.14 ± 0.05 | −0.19 ± 0.04 | <0.001 | |
| Times eat out per week | |||||||
| Baseline | 3.47 ± 0.15 | 3.59 ± 0.17 | 0.586 | 3.35 ± 0.08 | 3.48 ± 0.08 | 0.245 | 0.817 |
| Year 1 | 2.78 ± 0.16 | 3.06 ± 0.17 | 0.219 | 2.57 ± 0.07 | 3.12 ± 0.07 | <0.001 | |
| Change | −0.80 ± 0.13 | −0.32 ± 0.13 | 0.009 | −0.68 ± 0.07 | −0.31 ± 0.07 | <0.001 | |
Abbreviations: DSE, diabetes support and education; ILI, intensive lifestyle intervention.
Interaction between having children in the home and treatment arm by ANCOVA using linear regression (continuous outcome) or logistic regression (binary outcome).
x 2 test.
Two‐sample t test.
Question assessed times exercised per week to a level of exertion that caused ‘sweat, shortness of breath or a thumping heart’.